Markets:

Overview

News

Currencies

International

Treasuries

Teva Pharmaceutical Industries Limited American Depositary Shares (NY:TEVA)

30.77 -0.44 (-1.39%)

Streaming Delayed Price Updated: 10:14 AM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries Limited American Depositary Shares

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

31 32 Next >

How Former IBD 50 Leader Catalyst Pharma Is Trying To Claw Back From A 29% Setback ↗

January 25, 2023

Catalyst is adding to its portfolio with a $160 million deal.

Via Investor's Business Daily

Nasdaq Bear Market: 3 Screaming Bargains That Can Double Your Money by 2025 ↗

January 25, 2023

A 33% plunge in the Nasdaq Composite is the opportune time to scoop up these exceptional deals.

Via The Motley Fool

Dow, Nasdaq Boasting Triple-Digit Midday Lead ↗

January 23, 2023

Investors seem intent on leaving last week's losses behind, as earnings season heats up.

Via Talk Markets

Catalyst Pharma Shares Take A Hit As Teva Files For Generic Version Of Its Lead Product ↗

January 23, 2023

Via Benzinga

No. 1 IBD 50 Stock Catalyst Tanks As Teva Looks To Knock Off Its Only Product ↗

January 23, 2023

Shares have sat atop the IBD 50 for weeks, have perfect ratings and recently hit a profit-taking zone.

Via Investor's Business Daily

Analyst Ratings for Teva Pharmaceutical Indus ↗

January 19, 2023

Via Benzinga

3 Dirt Cheap Stocks to Buy in January ↗

January 14, 2023

Bargains can easily be found as the new year gets underway.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2023 ↗

January 19, 2023

Via Benzinga

Tesla To Rally Around 138%? Here Are 10 Other Analyst Forecasts For Thursday ↗

January 19, 2023

JP Morgan cut the price target for Apple Inc. (NASDAQ: AAPL) from $190 to $180. JP Morgan analyst Samik Chatterjee maintained an Overweight rating. Apple shares fell 1.1% to $133.70 in pre-market...

Via Benzinga

Teva’s Ambitious Climate Targets Externally Validated by the Science Based Targets initiative (SBTi)

January 19, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Organon Stock Scores Market Leadership With Jump To 83 RS Rating ↗

January 17, 2023

Organon sees its Relative Strength Rating reach the 80-plus level.

Via Investor's Business Daily

If You Invested $1,000 in Novavax In 2020, This Is How Much You Would Have Today ↗

January 13, 2023

The stock has gone on a wild ride over the past few years.

Via The Motley Fool

Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2022 Financial Results and 2023 Financial Guidance at 8 a.m. ET on February 8, 2023

January 12, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Most Active Equity Options For Midday - Wednesday, Jan. 11 ↗

January 11, 2023

Here are the most active equity options for midday.

Via Talk Markets

NVAX Stock Alert: What to Know as Novavax Names New CEO ↗

January 09, 2023

Although a change at the top boosted sentiment for Novavax, the harsh reality is that NVAX stock faces a mountain of worries.

Via InvestorPlace

Teva Announces Nationwide Opioids Settlement to Move Forward After Receiving Broad Support from States

January 09, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

4 Stocks That Actually Increased in 2022 -- And They're Still Worth Buying Now ↗

January 07, 2023

These all handily outperformed the market last year and could do the same in 2023.

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

January 06, 2023

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Alvotech and Teva Announce Acceptance of U.S. Biologics License Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab)

January 06, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Alvotech and Teva Announce Acceptance of U.S. Biologics License Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab)

January 06, 2023

From Alvotech

Via GlobeNewswire

Jazz Pharmaceuticals Files Patent Infringement Against Generic Drugmakers In New Jersey's District Court ↗

January 05, 2023

Jazz Pharmaceuticals (NASDAQ: JAZZ), a drug company behind the CBD-based medication Epidiolex, recently filed a lawsuit against Teva Pharmaceutical Industries Ltd (NYS

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

January 04, 2023

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

2023 Kick-Off With Apple Losing $2T With Big Option Trades On GLD And XLE ↗

January 03, 2023

While the tenor was more bearish, the late-day rally found the market close to where it finished 2022.

Via Talk Markets

Teva to Present at the 41st Annual J.P. Morgan Healthcare Conference

January 03, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

2 "Safe" Stocks That Are Anything But ↗

December 30, 2022

Sometimes, business models that sound safe still fail to deliver for shareholders.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

December 29, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Update on U.S. Regulatory Status of AVT02, Alvotech’s Proposed High-Concentration, Interchangeable Biosimilar to Humira®

December 22, 2022

From Alvotech

Via GlobeNewswire

My Top 5 Portfolio Holdings for 2023 ↗

December 21, 2022

This mix of growth and value stocks can outperform in a challenging environment.

Via The Motley Fool

Looking At Teva Pharmaceutical Indus's Recent Unusual Options Activity ↗

December 09, 2022

Someone with a lot of money to spend has taken a bearish stance on Teva Pharmaceutical Indus (NYSE:TEVA). And retail traders should know. We noticed this today when the big position showed up on...

Via Benzinga

Is Prometheus Biosciences a Good Stock to Buy Right Now? ↗

December 09, 2022

This biotech stock just jumped over 180% in a single day, and investors want to know if there could be more big gains ahead.

Via The Motley Fool

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

31 32 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.